Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minna Suvela

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Acta Oto-Laryngologica|March 28, 2008
Human herpesvirus-6 and -7 DNA in cerebrospinal fluid of facial palsy patientsMervi Kanerva, Anne J Jääskeläinen, Minna Suvela, et al.
Molecular and Cellular Probes|March 3, 2007
The enhancement of homogenous mass extension reaction: comparison of two enzymesPäivi Tikka-Kleemola, Eija Hämäläinen, Kari Tuomainen, et al.
Oncotarget|September 17, 2017
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testingMuntasir Mamun Majumder, Raija Silvennoinen, Pekka Anttila, et al.
Journal of Neuroimmunology|November 21, 2008
No evidence for shared etiology in two demyelinative disorders, MS and PLOSLAnna-Maija Sulonen, Suvi P Kallio, Pekka Ellonen, et al.
Hemasphere|March 4, 2022
The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell DeathKen Flanagan, Romika Kumari, Juho J Miettinen, et al.
Frontiers in Cell and Developmental Biology|September 6, 2021
S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple MyelomaMinxia Liu, Yinyin Wang, Juho J Miettinen, et al.
European Journal of Human Genetics : EJHG|January 15, 2009
MYO9B polymorphisms in multiple sclerosisAnu Kemppinen, Minna Suvela, Pentti J Tienari, et al.
Blood|June 17, 2017
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AMLRiikka Karjalainen, Tea Pemovska, Mihaela Popa, et al.
Human Molecular Genetics|February 18, 2009
Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MSSuvi P Kallio, Eveliina Jakkula, Shaun Purcell, et al.
Experimental Hematology & Oncology|December 24, 2025
Efficacy of melflufen in multiple myeloma with mutated or deleted TP53Klara Acs, Juho J Miettinen, Philipp Sergeev, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Acta Oto-Laryngologica|March 28, 2008
Human herpesvirus-6 and -7 DNA in cerebrospinal fluid of facial palsy patientsMervi Kanerva, Anne J Jääskeläinen, Minna Suvela, et al.
Molecular and Cellular Probes|March 3, 2007
The enhancement of homogenous mass extension reaction: comparison of two enzymesPäivi Tikka-Kleemola, Eija Hämäläinen, Kari Tuomainen, et al.
Oncotarget|September 17, 2017
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testingMuntasir Mamun Majumder, Raija Silvennoinen, Pekka Anttila, et al.
Journal of Neuroimmunology|November 21, 2008
No evidence for shared etiology in two demyelinative disorders, MS and PLOSLAnna-Maija Sulonen, Suvi P Kallio, Pekka Ellonen, et al.
Hemasphere|March 4, 2022
The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell DeathKen Flanagan, Romika Kumari, Juho J Miettinen, et al.
Frontiers in Cell and Developmental Biology|September 6, 2021
S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple MyelomaMinxia Liu, Yinyin Wang, Juho J Miettinen, et al.
European Journal of Human Genetics : EJHG|January 15, 2009
MYO9B polymorphisms in multiple sclerosisAnu Kemppinen, Minna Suvela, Pentti J Tienari, et al.
Blood|June 17, 2017
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AMLRiikka Karjalainen, Tea Pemovska, Mihaela Popa, et al.
Human Molecular Genetics|February 18, 2009
Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MSSuvi P Kallio, Eveliina Jakkula, Shaun Purcell, et al.
Experimental Hematology & Oncology|December 24, 2025
Efficacy of melflufen in multiple myeloma with mutated or deleted TP53Klara Acs, Juho J Miettinen, Philipp Sergeev, et al.
Pageof 2